 |
 |

National Adverse Drug Reaction Surveillance1986
Gerald A. Faich, MD, MPH;
Michael Dreis, RPh, MPH;
Dianne Tomita, MPH
Arch Intern Med. 1988;148(4):785-787.
Abstract
The collection of adverse drug reaction (ADR) reports by the Food and Drug Administration serves to provide additional information on the toxic reactions of drugs that often cannot be known before a drug is marketed. In 1986, a total of 53 547 ADR reports were received; 56% of these were made by US health care professionals based on observations made during usual clinical practice. The 1986 total represents an increase of 14% in ADR reporting over 1985, continuing a trend begun in 1981. While these increases are encouraging, US reporting rates are far below many other countries, and further encouragement of reporting must be done. Of these ADR reports, 24% involved serious reactions and 20% involved new drugs. An ADR report should be seen as a professional responsibility; reports are carefully analyzed and used.
(Arch Intern Med 1988;148:785-787)
Author Affiliations
From the Office of Epidemiology and Biostatistics, Center for Drug Evaluation, US Food and Drug Administration, Rockville, Md.
Footnotes
Accepted for publication Dec 28, 1987.
The views expressed herein are those of the authors and are not to be construed as official, or as reflecting the views of the US Food and Drug Administration.
Reprints not available.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Antiepileptics in the Elderly: Pharmacoepidemiology and Pharmacokinetics
Cloyd et al.
Arch Fam Med 1994;3:589-598.
ABSTRACT
Uses of Nonsteroidal Anti-inflammatory Drugs in Pediatrics
Lindsley
Arch Pediatr Adolesc Med 1993;147:229-236.
ABSTRACT
Recognizing Hospital Adverse Drug Reactions
Savitsky
Journal of Pharmacy Practice 1989;2:203-208.
ABSTRACT
Adverse Drug Reactions and the Food and Drug Administration
Pearson and Kennedy
Journal of Pharmacy Practice 1989;2:209-213.
ABSTRACT
Implementing a Hospital-Based Adverse Drug Reaction Reporting Program
Miwa
Journal of Pharmacy Practice 1989;2:214-220.
ABSTRACT
|